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Mast cell precursors are derived from multipotential hematopoietic stem cells,
migrate in the blood stream, and enter the tissue where they differentiate into
morphologically identifiable mast cells (reviewed in reference 1). The differen-
tiated mast cells may be classified into at least two phenotypically distinct
populations; connective tissue-type mast cells (CTMC) and mucosal mast cells
(MMC) (2-4). CTMC occur in the skin and peritoneal cavity, among other sites.
Classically, CTMC contain heparin proteoglycan and store relatively a large
amount of histamine. By contrast, MMC are prominent in the mucosal layer of
the gastrointestinal tract, and contain chondroitin sulfate proteoglycan and
relatively small quantities ofhistamine (2-4).
Investigations about differentiation ofmast cells have recently been promoted
by development of culture techniques. Cells with many features of MMC devel-
oped in suspension cultures ofnormal mouse hematopoietic cells containing mast
cell growth factors (reviewed in references 2-4). Both MMC and cultured mast
cells are exquisitely sensitive to T cell regulation. Striking proliferation of MMC
occurs during Tcell-dependent responsestocertain intestinal parasitesin normal
mice and rats (5, 6). By contrast, athymic nude mice lack such a response (6).
The nude mouse intestinal mucosa contains MMC precursors (5), however, and
MMC proliferation does occur if nude mice are reconstituted with T cells before
intestinal infection (6). Cultured mast cells proliferate in response to mast cell
growth factors, which can be elaborated by T cells (reviewed in references 2-4).
Two distinct T cell factors are known to support proliferation ofcultured mast
cells. Ihle et al. (7) purified IL-3 from WEHI-3 cell supernatants. A mast cell
growth factor produced by a concanavalin A-stimulated helper T cell line was
demonstrated to be identical with IL-3 (8, 9). Smith and Renick (10) recently
identified another mast cell growth factor in supernatants of the same T cell
line; Lee et al. (11) isolated and characterized cDNA clone that encoded this
mast cell growth factor. Unexpectedly, the nucleotide sequence of the cDNA
was identical with that of cDNA encoding the IgGl-inducing factor isolated by
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Noma et al. (12). Because a peptide encoded by this cDNA showed multiple
biological activities, the peptide was designated as interleukin 4 (IL-4) (10-12).
In contrast with the exquisite sensitivity of MMC and cultured mast cells to T
cell regulation, CTMC have been considered to show little or no dependence on
T cell-derived factors (2, 3). Numbers of CTMC in the skins and peritoneal
cavities ofnude mice are comparable to those observed in control normal animals
(6). However, Kobayashi et al . (13) and Nakahata et al. (14) recently demon-
strated that pure mast cell colonies developed when peritoneal mast cells of mice
were plated in methylcellulose containing pokeweed mitogen-stimulated spleen
cell-conditioned medium (PWM-SCM).
In the present study, we investigated growth factors that supported clonal
proliferation of CTMC, and demonstrated that PWM-stimulated spleen cells
contain mRNA for both IL-3 and IL-4, and that the presence of both interleukins
was necessary for development of mast cell clusters from CTMC .
Materials and Methods
Cell Suspension.
￿
Mice of (WB x C57BL/6)F, were raised in our laboratory, and used
at 8-10 mo of age. The method to prepare cell suspensions has been described (4).
Purification ofPeritoneal Mast Cells.
￿
The major compenents of mouse peritoneal cells
are macrophages and small lymphocytes. They were removed according to the method
described by Yurt et al. (15). Peritoneal cells from 10 mice were collected by lavage of
peritoneal cavity of each mouse with 5 ml of Tyrode's buffer containing 0 .1 % gelatin
(Sigma Chemical Co., St . Louis, MO). The cells were sedimented at 400 g for 15 min
at room temperature, and washed twice with Tyrode's buffer containing 0.1% gelatin .
^-6 x 107-10 cells in I ml of the Tyrode's buffer were layered on 2.0 ml of 22.5% wt/vol
metrizamide (density, 1 .125 g/ml) and centrifuged at room temperature for 15 min at
400 g at the buffer-metrizamide interface. The cells remaining at this interface were
aspirated and discarded ; the cells in the pellet were washed and resuspended in 1 .0 ml of
Tyrode's buffer. Of the nucleated cells in this preparation, ^-80% were mast cells. To
obtain mast cell suspension of 99% purity, the above-mentioned procedure was repeated
by using the 80%-pure mast cell suspension.
Conditioned Medium.
￿
PWM-SCM was prepared according to the method described by
Nakahata and Ogawa (16).
Lymphokines.
￿
IL-3 purified from WEHI-3 supernatant was a gift ofJ. N. Ihle (National
Cancer Institute, Frederick, MD) (7). We synthesized IL-4 according to the method
described previously (12). Briefly, pSPKmIL4-374 plasmid containing the full-length IL-
4 cDNA was cleaved with Sall to be linealized. Capped IL-4 mRNA was synthesized using
SP6 RNA polymerase. The synthesized mRNA was injected into Xenopus oocytes, and
translation products secreted into the incubation media were collected. We used this
incubation media as recombinant IL-4 (rIL-4).
Northern Blot Hybridazation.
￿
Total cellular RNA was extracted from cells using the
guanidium thiocyanate method (12), and was separated on a agarose/formaldehyde gel
and then transferred to a nitrocellulose filter.
Clonal Cell Culture.
￿
Methylcellulose culture were carried out by using a modification
of the technique described previously (13). 1 ml of culture mixture containing 103
peritoneal mast cells, a-medium (Flow Laboratories), 1 .0% methylcellulose (Sigma Chem-
ical Co.), 30% FCS (Flow Laboratories), 1 % deionized BSA (Sigma Chemical Co.), 10'
M 2-ME (Sigma Chemical Co.), and 10% of PWM-SCM or 10% of a-medium containing
various amounts of lymphokines was plated and incubated at 37° C in humidified atmos-
phere flushed with 5% COz in air. Large clusters containing ?32 cells and small clusters
containing 4-31 cells were counted on day 14.
Staining of Cells.
￿
Cells from individual colonies were collected as described by Kobay-
ashi et al. (13). After washing with PBS, samples were immediately spun in a cytocentrifuge270
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FIGURE 1 .
￿
(A)RNA blot analysis of 25 i+g of total cellular RNA isolated from WEHI-3 cell
line (lane 1) or unstimulated (lane 2) or PWM-stimulated (lane 3) spleen cells . 1.1 kb Eco RI
fragment of a mouse IL-3 clone (9) was used as a probe. (B) RNA blot analysis of 25 Ag of
total cellular RNA isolated from 2.19T cells (12) (lane 1) or WEHI-3 cell line (lane 2), or
unstimulated (lane 3) or PWM-stimulated (lane 4) spleen cells . 360 by Rsa I fragment of a
mouse IL-4 clone (12) was used as a probe .
(Cytospin ; Shadon Southern, Elliott, IL) at 600 rpm for 5 min andwere stainedwith May-
Griinwald-Giemsa, alcian blue, or berberine sulfate . Berberine sulfate is a fluorescent dye
that binds to heparin proteoglycan in granules ofmouseCTMC (4) .
Results
PWM-SCM is probably a mixture of various growth factors . We examined
whether PWM-stimulated spleen cells produced IL-3 and IL-4 by Northern blot
hybridization . PWM-stimulated spleen cells contained both IL-3 and IL-4
mRNA, but the control nonstimulated spleen cells contained neither . Since
supernatants of WEHI-3 cells are frequently used as a source of mast cell growth
factor, RNA from WEHI-3 cells was also examined . As shown in Fig . 1, WEHI-
3 cells contained mRNA for IL-3 but not for IL-4 .
In the next experiment, we investigated the effect of purified IL-3 and rIL-4
on proliferation of mast cells collected from the peritoneal cavities, a classical
source ofCTMC . Since major components of murine peritoneal cells are lym-
phocytes and macrophages, mast cells were highly purified (99%) and used as
the target in order to minimize the effect of factors secreted by lymphocytes and
macrophages . 10' peritoneal mast cells were plated with PWM-SCM, IL-3, or
rIL-4. PWM-SCM supported proliferation of mast cells; about one-fifth of mast
cells produced small (4-31) or large (?32) clusters in methylcellulose (Table I) .
IL-3 alone induced development of a small number of clusters, and most ofthem
were small in size . No clusters appeared in dishes supplemented with rIL-4 alone .
However, when rIL-4 was added to IL-3 (50 U), the number and size of clusters
were comparable to the values observed in dishes supplemented with PWM-SCMHAMAGUCHI ET AL.
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TABLE I
Mast Cell Clusters 14 d after Plating 10' Peritoneal Mast Cells with Various Growth Factors
* Results are the mean of four dishes in exp. 1, the mean of two dishes in exp. 2.
= Units of IL-3 as defined by Ihle et al. (7); percentage of PWM-SCM or rIL-4 to total culture medium.
(Table 1). Although a small quantity (0.5%) of rIL-4 was enough to synergize
with IL-3, control supernatant ofXenopus eggs that had not been injected with
IL-4 mRNA did not show any activities even in a large quantity (10%) (data not
shown).
Cells from mast cell clusters were stained with various dyes; granules of the
majority of the cells stained with either May-Gruwal-Giemsa or alcian blue.
About 70% of cells contained granules that stained with berberine sulfate,
suggesting the presence ofheparin in granules ofdeveloping mast cells.
Discussion
Factors that support the growth of mast cells in culture have extensively been
investigated. Purified IL-3 supportsdevelopmentofmast cells from bone marrow
precursors in either liquid (2, 3) or semisolid (17) culture medium. When mast
cells lines are used as the target, either IL-3 or IL-4 supports the growth (10,
11, 18). Sincephenotypes ofbone marrow-derived cultured mast cells, including
mast cell lines, are similar to MMC (2, 3), these results have been considered as
evidence forTcell dependency ofMMC. In contrast to MMC, CTMC have been
supposed to be independent on T cells (2, 6). However, the present results
clearly demonstrated that the in vitro growth of CTMC may also be induced by
combination of IL-3 and IL-4.
IL-3 alone supported development of a small number of clusters from perito-
neal mast cells, typical CTMC, but the addition of rIL-4 to IL-3 increased the
number of clusters by a factor of 10. Since no clusters developed in dishes
supplemented with rIL-4 alone, IL-4 seems to act as a cofactor of IL-3. This
probably reflects a physiological function ofIL-4 to CTMC.
Differentiation of mast cells have a unique feature. The progeny of multipo-
tential hematopoietic stem cells, such as erythrocytes, neutrophils, and platelets,
leave the bone marrow after maturation, and they do not divide thereafter.
Expt.*
Factors*
PWM-SCM
added to growth
IL-3
U
medium
rIL-4 Small (4-31)
Number ofclusters
Large (>_32) Total
1 0 0 0 0 0 0
10 0 0 137 65 202
0 50 0 16 0 16
0 50 5.0 190 11 201
0 0 5.0 0 0 0
2 0 0 0 0 0 0
10 0 0 158 81 239
0 50 0 27 1 28
0 50 0.5 218 83 301
0 50 2.0 217 109 326
0 50 5.0 262 118 380
0 50 10.0 175 84 259
0 0 5.0 0 0 0
0 0 10.0 0 0 0272
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Although mast cells are progeny ofstem cells as well, either CTMC or cultured
mast cells have extensive proliferation activity even after morphological differ-
entiation (1, 13, 14, 19). Since CTMC rarely divide in physiological conditions
(2, 19), the present result suggests that IL-4 may be an immunological signal that
initiates the division ofCTMC. IL-4 was reported to activate resting B cells (I8).
There is a possibility that the same mechanism may be used for activation of
both CTMC and resting B cells.
IL-4 also enhances IgE production by B cells (10, 11, 18). There is a possibility
that IL-4 secreted by T cells may locally induce proliferation of mast cells and
IgE production at the same time. This may facilitate a local defense mechanism
operated by IgE and mast cells, since high-affinity IgE receptors are present on
the surface of mast cells.
Summary
We investigated the biological activity of IL-4 to murine connective tissue-
type mast cells (CTMC). When purified peritoneal mast cells, typical CTMC,
were incubated with pokeweed mitogen-stimulated spleen cell-conditioned me-
dium (PWM-SCM) in methylcellulose, about one-fifth ofmast cells showed clonal
growth. Recombinant IL-4 alone did not stimulate the clonal growth, and
purified IL-3 alone induced development of a small number of tiny clusters. In
contrast, addition of IL-4 to IL-3 increased the number ofclusters by a factor of
10. The number and size ofclusters induced by the combination of IL-3 and IL-
4 were comparable to those of mast cell clusters induced by PWM-SCM. The
present results indicate that IL-4 is an essential factor for in vitro clonal growth
of CTMC.
We thank Dr. James N . Ihle for providing purified IL-3.
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